We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Genetic Markers May Predict Prostate Cancer in Younger Men

By LabMedica International staff writers
Posted on 12 Jul 2010
Prostate cancer has become more common in younger men, and it is frequently more aggressive. A new study has found that a series of genetic mutations could help detect this early onset prostate cancer.

Researchers believe that genetics and traditional screening techniques could play a role in predicting the risk of prostate cancer in younger men. "This is a potential opportunity to combine PSA [prostate-specific antigen] testing with genetic markers to determine who has significant prostate cancer. It could be a combination of age and family history that could help us determine who should be tested with PSA and a panel of genetic markers,” stated study author Kathleen Cooney, M.D., professor of hematology/oncology and division chief of hematology/oncology at the University of Michigan (U-M) Medical School (Ann Arbor, MI, USA).

Researchers looked for 14 different gene mutations in 754 men age 56 and younger with prostate cancer. The men were enrolled in the Prostate Cancer Genetics Project at U-M. Researchers also looked at 1,163 older men with prostate cancer and 2,713 men without prostate cancer. The study, which was presented June 2010 at the American Society of Clinical Oncology annual meeting, held in Chicago, IL, USA, discovered that the younger men carried more of these genetic mutations. Moreover, 30% of the younger men had aggressive prostate cancer and 41% of these men had at least one first-degree relative with prostate cancer.

"Early onset prostate cancer has a strong genetic component, which we saw in this study. The genetic variants we looked at here are likely not the best indicators. Our next step is to look more widely for common genetic variants among this group of men,” Dr. Cooney stated.

The researchers continue to enroll men in this study. They will next examine the genome of a larger population of men with early onset prostate cancer to find common mutations that may be linked to the disease.

Related Links:

University of Michigan (U-M) Medical School




Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA

Latest Molecular Diagnostics News

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer
12 Jul 2010  |   Molecular Diagnostics

Ultrarapid Whole Genome Sequencing for Neonatal and Pediatric Patients Delivers Results In 48 Hours
12 Jul 2010  |   Molecular Diagnostics

AI-Enabled Blood Test Demonstrates Diagnostic, Prognostic and Predictive Utility Across Cancer Continuum
12 Jul 2010  |   Molecular Diagnostics



PURITAN MEDICAL